Literature DB >> 12722739

125I-BMIPP and 18F-FDG uptake in a transgenic mouse model of stunned myocardium.

Hein J Verberne1, Gerrit W Sloof, Arnold L Beets, Anne M Murphy, Berthe L F van Eck-Smit, Furn F Knapp.   

Abstract

Reported metabolic patterns in myocardial stunning are not uniform. We investigated relative myocardial perfusion, glucose and fatty acid uptake using a technetium-99 hexakis-2-methoxyisobutyl-isonitrile (MIBI), fluorine-18 2-fluoro-2-deoxyglucose (FDG) and iodine-125 15-(p-iodo-phenyl)-3(R,S)-methylpentadecanoic acid (BMIPP) mixture, in a recently developed transgenic (TR) mouse model which mimics stunned myocardium. Twenty-seven mice - 14 TR and 13 age-matched wild type controls (C) - were divided into four groups: TR-fed, TR-fasted, C-fed and C-fasted. Animals were sacrificed 2 h after injection, tissue samples counted and percent-injected dose/gram tissue (% id/g) calculated for each radioisotope. Tissues were also Folch extracted and 125I incorporation into the various lipid pools (TG, triglycerides; DG, diglycerides; FFA, free fatty acids; PL, phospholipids) was determined by thin-layer chromatography (TLC). The pooled data for each of the four groups (TR-fed vs C-fed and TR-fed vs C-fasted) showed no differences in myocardial blood flow (% MIBI id/g), glucose uptake (% FDG id/g) or fatty acid uptake (% BMIPP id/g). Only minor differences were observed in the incorporation of 125I-BMIPP into the myocardial TG, DG, FFA and PL lipid pools. However, significantly decreased myocardial FDG uptake was observed in a subset of fasted mice - four out of ten TR-fasted mice (3.4% vs 20.5% id/g) and three out of nine C-fasted mice (5.5% vs 30.6% id/g). The transgenic mouse model of stunned myocardium shows normal myocardial perfusion and overall intact myocardial glucose and myocardial fatty acid uptake as determined with clinically applicable radiolabelled analogues. These data are in line with the hypothesis that the contractile inefficiency in stunned myocardium is not linked to metabolic alterations but is associated with an insufficient chemical to mechanical energy coupling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722739     DOI: 10.1007/s00259-002-0999-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  5 in total

1.  Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction.

Authors:  Yoshitomo Fukuoka; Akira Nakano; Naoto Tama; Kanae Hasegawa; Hiroyuki Ikeda; Tetsuji Morishita; Kentaro Ishida; Kenichi Kaseno; Naoki Amaya; Hiroyasu Uzui; Hidehiko Okazawa; Hiroshi Tada
Journal:  J Nucl Cardiol       Date:  2016-06-14       Impact factor: 5.952

2.  Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection.

Authors:  Kevin P Daly; Jason L J Dearling; Tatsuichiro Seto; Patricia Dunning; Frederic Fahey; Alan B Packard; David M Briscoe
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

3.  High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance.

Authors:  Anisha A Gupte; Laurie J Minze; Maricela Reyes; Yuelan Ren; Xukui Wang; Gerd Brunner; Mohamad Ghosn; Andrea M Cordero-Reyes; Karen Ding; Domenico Pratico; Joel Morrisett; Zheng-Zheng Shi; Dale J Hamilton; Christopher J Lyon; Willa A Hsueh
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

4.  Long chain fatty acid uptake in vivo: comparison of [125I]-BMIPP and [3H]-bromopalmitate.

Authors:  Jane Shearer; Kimberly R Coenen; R Richard Pencek; Larry L Swift; David H Wasserman; Jeffrey N Rottman
Journal:  Lipids       Date:  2008-05-15       Impact factor: 1.880

5.  Positron emission tomography imaging of conditional gene activation in the heart.

Authors:  Gwendolen Y Chang; Feng Cao; Manickam Krishnan; Mei Huang; Zongjin Li; Xiaoyan Xie; Ahmad Y Sheikh; Grant Hoyt; Robert C Robbins; Tzung Hsiai; Michael D Schneider; Joseph C Wu
Journal:  J Mol Cell Cardiol       Date:  2007-03-24       Impact factor: 5.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.